MedPath

TERBASMIN EXPECTORANTE 0,3 mg/ml + 13,3 mg/ml SOLUCION ORAL

TERBASMIN EXPECTORANTE 0,3 mg/ml + 13,3 mg/ml SOLUCION ORAL

Commercialized
Register Number

54883

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Sep 30, 1979

Dosage Form

SOLUCIÓN ORAL

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number54883
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (2)

GUAIFENESINAActive
Quantity: 1,33 g
Name: GUAIFENESINA
TERBUTALINA SULFATOActive
Quantity: 0,03 g
Name: TERBUTALINA SULFATO

ATC CLASSIFICATION (3)

R03C
R03CC
R03CC53

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.